Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 87 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Chemotherapy with MeGAG or CLZ or AMSA or CTX/VCR/MTX for Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-1277R


2.		Phase III Combination Chemotherapy with CACP/DAVA/MeGAG for Metastatic or Recurrent Epidermoid Carcinoma of the Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MSKCC-8241


3.		Phase III Chemotherapy with MIME (MeGAG/IPP/MTX/VP-16) for Hodgkin's and non-Hodgkin's (All Stages) Lymphoma in Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over								MDA-DT-8150


4.		Phase III Combination Chemotherapy with CACP/VBL/MeGAG for Locally Unresectable or Metastatic Epidermoid Carcinoma of the Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D82-035-648


5.		Phase III CACP/VP-16 vs CACP/VP-16/MeGAG vs CACP/VBL vs CACP/VBL/MITO vs 5-FU/VCR/MITO--CTX/ADR/CACP in Stage III non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				SWOG-8241

Last Modified: 2/1/1988


6.		Phase III Randomized Comparison of Radiotherapy vs Combination Chemotherapy with DFMO/MEGAG vs No Postoperative Therapy in Patients with Non-Enhancing Moderately and Mildly Anaplastic Gliomas of the Brain (Summary Last Modified 02/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				5 to 45				NCI				NCOG-6G871 BTRC-8625, MDA-DM-88056, NCI-T86-0226D, T86-0226


7.		Phase I/II Pilot Chemotherapy with CVeM (VBL/CACP/MeGAG) for Metastatic Stage III non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								UMCT-1682


8.		Phase I/II Chemotherapy with Methyl-GAG for Advanced and Incurable Lymphoma, Leukemia, or Solid Tumors in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				21 to 75								UMCT-1981


9.		Phase I/II Chemotherapy with DFMO/MGBG in Patients with Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				MSKCC-8525A NCI-T85-0043D, T85-0043


10.		Phase II Chemotherapy with Methyl-GAG for Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MDA-MBDT-7932

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute